Subcutaneous Drug Delivery Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering medications such as insulin, morphine, diacetylmorphine and goserelin.
MARKET DYNAMICS
The subcutaneous drug delivery market in robust R&D activities is resulting from an increasing number of pipeline products, which may drive the growth of the global subcutaneous drug delivery market. However, the rise in awareness about the presence of subcutaneous drug deliverys has lowered ignorance toward venom-bites, which is restraining the market growth. Moreover, presence of large population density in countries such as China, India and Brazil, where there is high prevalence of bacterial diseases, favorable reimbursement scenario for treatments and medications, is expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Subcutaneous Drug Delivery Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of in subcutaneous drug delivery market with detailed market segmentation by technology type, type, product type, distribution channel and geography. The subcutaneous drug delivery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in subcutaneous drug delivery market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The subcutaneous drug delivery market is segmented on the basis of product type, type, and technology type and distribution channel. Based on product type the market is segmented as fillable injectable and prefilled injectable. On the basis of type the market is categorized as disposable subcutaneous drug delivery injectable and reusable subcutaneous drug delivery injectable. On the basis of technology type the market is categorized as jet, spring and gas. Based on the basis of distribution channel the market is categorized as hospital pharmacies, retail pharmacies, drug store and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in subcutaneous drug delivery market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The subcutaneous drug delivery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting subcutaneous drug delivery market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the subcutaneous drug delivery market in these regions.
By Product Type
By Type
By Technology type
By Distribution Channel
MARKET PLAYERS
The report covers key developments in the in subcutaneous drug delivery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in subcutaneous drug delivery market are anticipated to have lucrative growth opportunities in the future with the rising demand for in subcutaneous drug delivery market in the global market. Below mentioned is the list of few companies engaged in the subcutaneous drug delivery market.
The report also includes the profiles of key in subcutaneous drug delivery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Amgen Inc
- Becton, Dickinson and Company
- Consort Medical plc.
- Elcam Medical
- F. Hoffmann-La Roche AG
- Genentech, Inc.
- scPharmaceuticals, Inc.
- Sensile Medical AG
- West Pharmaceutical Services, Inc.
- Ypsomed AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering medications such as insulin, morphine, diacetylmorphine and goserelin.
MARKET DYNAMICS
The subcutaneous drug delivery market in robust R&D activities is resulting from an increasing number of pipeline products, which may drive the growth of the global subcutaneous drug delivery market. However, the rise in awareness about the presence of subcutaneous drug deliverys has lowered ignorance toward venom-bites, which is restraining the market growth. Moreover, presence of large population density in countries such as China, India and Brazil, where there is high prevalence of bacterial diseases, favorable reimbursement scenario for treatments and medications, is expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Subcutaneous Drug Delivery Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of in subcutaneous drug delivery market with detailed market segmentation by technology type, type, product type, distribution channel and geography. The subcutaneous drug delivery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in subcutaneous drug delivery market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The subcutaneous drug delivery market is segmented on the basis of product type, type, and technology type and distribution channel. Based on product type the market is segmented as fillable injectable and prefilled injectable. On the basis of type the market is categorized as disposable subcutaneous drug delivery injectable and reusable subcutaneous drug delivery injectable. On the basis of technology type the market is categorized as jet, spring and gas. Based on the basis of distribution channel the market is categorized as hospital pharmacies, retail pharmacies, drug store and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in subcutaneous drug delivery market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The subcutaneous drug delivery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting subcutaneous drug delivery market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the subcutaneous drug delivery market in these regions.
Subcutaneous Drug Delivery Market Report Analysis
Subcutaneous Drug Delivery Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Amgen Inc
- Becton, Dickinson and Company
- Consort Medical plc.
- Elcam Medical
- F. Hoffmann-La Roche AG
- Genentech, Inc.
- scPharmaceuticals, Inc.
- Sensile Medical AG
- West Pharmaceutical Services, Inc.
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- Fillable Injectable
- Prefilled Injectable
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- Disposable subcutaneous drug delivery injectable
- Reusable subcutaneous drug delivery injectable
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- Jet
- Spring
- Gas
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- Hospital Pharmacies
- Retail Pharmacies
- Drug store
- Online Pharmacies
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the in subcutaneous drug delivery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in subcutaneous drug delivery market are anticipated to have lucrative growth opportunities in the future with the rising demand for in subcutaneous drug delivery market in the global market. Below mentioned is the list of few companies engaged in the subcutaneous drug delivery market.
The report also includes the profiles of key in subcutaneous drug delivery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Amgen Inc
- Becton, Dickinson and Company
- Consort Medical plc.
- Elcam Medical
- F. Hoffmann-La Roche AG
- Genentech, Inc.
- scPharmaceuticals, Inc.
- Sensile Medical AG
- West Pharmaceutical Services, Inc.
- Ypsomed AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Subcutaneous Drug Delivery Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
The List of Companies
1. Amgen Inc
2. Becton, Dickinson and Company
3. Consort Medical plc.
4. Elcam Medical
5. F. Hoffmann-La Roche AG
6. Genentech, Inc.
7. scPharmaceuticals, Inc.
8. Sensile Medical AG
9. West Pharmaceutical Services, Inc.
10. Ypsomed AG
1. Amgen Inc
2. Becton, Dickinson and Company
3. Consort Medical plc.
4. Elcam Medical
5. F. Hoffmann-La Roche AG
6. Genentech, Inc.
7. scPharmaceuticals, Inc.
8. Sensile Medical AG
9. West Pharmaceutical Services, Inc.
10. Ypsomed AG